← Back to Search

Injectable Medication Platforms for Medical Treatments

N/A
Recruiting
Led By Gaurav Gupta, MD
Research Sponsored by Canadian Forces Health Services Centre Ottawa
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately after intervention
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing different types of autoinjectors to see which is the most efficient at delivering medication.

Who is the study for?
This trial is for adults over 18 who can consent and have not used medication injections in the past year. It's not for healthcare workers with recent injection experience or those with conditions affecting thinking or hand coordination, as well as anyone with recent substance use.
What is being tested?
The study compares different methods of injecting emergency medications: autoinjectors, standard injectors, and prefilled syringes. The goal is to find out which method delivers medicine most efficiently during emergencies like severe allergies or overdoses.
What are the potential side effects?
While the trial focuses on delivery methods rather than medications themselves, potential side effects may include pain at the injection site, bruising, allergic reactions to components of the injector device, or complications from incorrect usage.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately after intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately after intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in medication Injection/delivery time for each trial
Secondary study objectives
Number of injection failures and/or injuries associated with each trial
Perceived difficulty of injection based on type of system

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Injection ScenarioExperimental Treatment3 Interventions
For each scenario participants will be asked to administer/inject the "medication" (likely saline or air) using various methods: 1) standard protocol , 2) Autoinjector 3) Pre-filled syringes. For each scenario the appropriate medication administration type will have to be selected amongst groups of options: 1) autoinjectors equivalents (ie medication, needle and syringe attached) 2) prefilled syringes where a needle is attached prior to administration; and 3) standard protocol (i.e. drawing medication from the vial and injecting via syringe/22 gauge needle). Medications options will include 1) Naloxone (opioid overdose) 2) Epinephrine (anaphylaxis) 3) Tranexamic acid (bleeding).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Autoinjector
2016
Completed Phase 3
~440

Find a Location

Who is running the clinical trial?

Canadian Forces Health Services Centre OttawaLead Sponsor
9 Previous Clinical Trials
1,199 Total Patients Enrolled
Gaurav Gupta, MDPrincipal InvestigatorCAF
6 Previous Clinical Trials
172 Total Patients Enrolled
1 Trials studying Hemorrhage
5 Patients Enrolled for Hemorrhage

Media Library

Prefilled Clinical Trial Eligibility Overview. Trial Name: NCT05367531 — N/A
Hemorrhage Research Study Groups: Injection Scenario
Hemorrhage Clinical Trial 2023: Prefilled Highlights & Side Effects. Trial Name: NCT05367531 — N/A
Prefilled 2023 Treatment Timeline for Medical Study. Trial Name: NCT05367531 — N/A
~8 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top